KB-3061 (BPN-25203)
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Drugs in Development
Phase Of Development
Preclinical
Sponsors and Collaborators
Knopp Biosciences
Mechanism of Action
Ion Channel
Mechanism Description
Potassium channel KV7.2/7.3 activators
Populations Tested In
N/A
Other Resources
Special FDA Designation
Nonprofit or Government Support
Government
Nonprofit or Government Support Description
NINDS - Blueprint neurotherapeutics grant
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
Epilepsy Precision Medicine Conference-September 2019
Location of Clinical Trials
N/A
Clinical Trial link